Ann: Quarterly Activities and Cashflow Report, page-119

First 119 Last

Share
Profile

Follow
sharebroker1

11,185 Posts.

684

28/07/24

19:45

Post #: 74952491
Share

Originally posted by the technician: ↑

Your post are very emotional and NO they're not coherent that being said read and learn Spud .

The lithium market is only dead for those that sell to China and even then HR is the major casualty not Brine . ASN does not sell to China and is not HR so this is just FUD .

ASN is not under an "environmental halt" on the contrary it is producing with a new US partner continually as we speak - What you are referring to is Brine extraction permit that is set to start works in 3 years time . SO AGAIN MORE FUD BY YOU SPUD .

why would ASN stop developing a Trillion $$$ resource when they are in the cusp of Producing commercially .

As you've stated burning through
"$8million per quarter" ??
This is again more FUD as the June quarter costs were the last of the extraction well drilling and plant setup CAPEX which was not project funded for but is here anyway ........ BONUS !!!!!!!

next quarter should see a more respectable $2 million spend IMO .

Now to the reasons you are commenting here as your a MAN holder and you are frustrated that MAN management have done nothing for the quarter and this is even more frustrating when you know that :

A) they have BLM permits in place to reenter 2 wells and can build a resource this was achieved 6 months ago .

B) they have had a drilling company secured to drill/reenter for the same 6 months or more .

C) they have ample cash to complete the task without hurting the bank balance ...... I mean they are only reentries with a work over rig not new drilling so roughly $300k per well not exactly bank busting but yet they hesitate ?????

D) last but not least the cash they have atm was raised to develop WA , CHN nearology projects not US brine projects what a conundrum maybe this is the reason MAN SHs have been left holding the bag with US brine drilling ?????

You can push your FUD all you want SPUD but it's amateurish at best and IMO I see nothing but PROGRESS at ASN and i see nothing but LIFESTYLE at MAN the 2 companies and management couldn't be any different ........ 100%

One last thing you say MAN have 45 years of funded quarters fine let's just take your word for it , have you stopped to consider that you will see no return for investment for 45 years ? I mean it's highly likely you would be dead and buried and it may be your kids or the government that "MAY" and that's a big maybe see that return ?

I think if the narrative doesn't change at MAN your up sheet creek without a paddle SPUD .

Expand

Who is talking FUD?

you said and I quote
"ASN is not under an "environmental halt"

Hang on answer me this yes or no.

As you saying the ASN Green River environmental halt has been lifted? a yes or a no please.

ASN Price at posting: 12.0¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 109 more messages in this thread...

First 119 Last

Add ASN (ASX) to my watchlist

(20min delay)
Last 7.7¢		Change 0.003(4.05%)		Mkt cap ! $104.2M

Open	High	Low	Value	Volume
7.5¢	7.7¢	7.5¢	$162.5K	2.151M

Buyers (Bids)

No.	Vol.	Price($)
3	64533	7.6¢

Sellers (Offers)

Price($)	Vol.	No.
7.7¢	227952	2

View Market Depth

No.	Vol.	Price($)
3	64533	0.076
3	300680	0.075
11	786453	0.074
8	650423	0.073
10	761506	0.072

Price($)	Vol.	No.
0.077	227952	2
0.079	583307	5
0.080	1193808	4
0.081	1226780	5
0.082	300000	1

Last trade - 16.10pm 07/10/2024 (20 minute delay)

ASN (ASX) Chart

Ann: Quarterly Activities and Cashflow Report, page-119

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Activities and Cashflow Report, page-119

Top Stories

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News